“A jingoism about British jobs for British workers”
By Helen Roxburgh - 12 August 10:39

Norman Rose on the Tesco immigration scandal.

Yet more domestic violence amongst the wealthy
By Sophie McBain - 12 August 10:24

Retail heir Damian Brenninkmeyer pleaded guilty to hitting wife across the face.

New Statesman
Samsung violated two Apple patents
By New Statesman - 12 August 9:20

The US International Trade Commission bans import of Samsung products affected by its ruling.

New Statesman
Rockwell Collins to buy ARINC for $1.39bn
By New Statesman - 12 August 9:15

The transaction will combine ARINC’s networks and services with the avionics and cabin technologies of Rockwell Collins.

New Statesman
Japan’s GDP up 0.6 per cent in second-quarter
By New Statesman - 12 August 9:03

The world’s third-largest economy grew at an annualised rate of 2.6 per cent; growth slower than expected.

New Statesman
Morning Wrap: today's top business stories
By New Statesman - 12 August 9:00

News stories from around the web.

Tesco.
Five questions answered on Tesco’s talks with China Resources
By Heidi Vella - 09 August 12:27

A win-win move, or do Tesco still just not understand China?

Rebuilding Bebo: Shaan Puri reveals his plans for the social network
By James Evans - 09 August 11:20

"The biggest lesson is that the social products that succeed are non-obvious"

Bank of England.
Bank of England joins the "forward guidance" party
By Nick Beecroft - 08 August 16:32

The Bank of England's Monetary Policy Committee has announced that they will adopt "forward guidance" - a move which could prove psychologically self-defeating, or worse financially ruinous.

We shouldn't be hanging on the every word of Britain’s new "superstar" central banker
By Jeremy Green - 08 August 12:42

Britain's economic debate needs to be more daring than the Bank of England can ever be, writes Jeremy Green.

Roche.
NICE snubs Roche’s new breast cancer drug
By Heidi Vella - 07 August 16:19

The UK's health cost watchdog, the National Institute for Care and Excellence, has rejected Roche's newest cancer drug Perjeta - the seventh such cancer drug to be by NICE since 2011.

Chris Grayling.
Barrister to Chris Grayling: "Come and do work experience"
By Mark Nayler - 07 August 12:24

Fearing his lack of experience with publicly-funded criminal cases, Sarah Forshaw QC wants to offer the justice secretary a "Mini Pupillage" to show him why justice is being compromised, and not all barristers are "fat cats".

Late, getting later: speeding up payments would speed up growth
By Nigel Knowles - 05 August 18:00

£35bn is owed to small and medium businesses. That needs to fall, or it's the whole country which will pay the bill.

Escaping the “black hole”: how to measure cybercrime
By James Petter - 05 August 16:57

How big a threat is cybercrime to UK industry, and how do we deal with it?

Train.
We need good infrastructure to get our regions working again
By Mark Walley - 05 August 16:04

Enterprise zones and beyond: good roads, high speed broadband and functioning transport hubs are essential to ensure prosperity for all.

HSBC.
Five questions answered on HSBC’s profit rise
By Heidi Vella - 05 August 15:13

How did they do it?

Clocks.
An evil still lurks at the heart of the British economy: lateness
By Nigel Knowles - 05 August 15:05

Cash flow problems account for a huge percentage of corporate bankruptcies. A change in the law, and our culture, might just give the economy a much-needed boost.

New Statesman
Five questions answered on a new survey about the UK’s finances
By Heidi Vella - 02 August 12:53

The Money Advice Service has released the results of its latest survey into people’s finances. We answer five questions on the survey’s results.

The EU's cat-herder-in-chief fails to move the markets where he wants
By Nick Beecroft - 02 August 9:47

Mario Draghi strained to have an effect, but to no avail.

New Statesman
Carl Icahn files lawsuit against Dell
By new-statesman - 02 August 9:05

The activist investor alleges Dell and its board attempted to block $24.4bn buyout proposal.

New Statesman
Manhattan federal court charges Fabrice Tourre with $1bn fraud
By new-statesman - 02 August 8:31

SEC wins in high-profile trial.

Why are foreign investments in the UK rising?
By Sara Perria - 01 August 14:11

Is it just the weather?

“I never got complacent”
By Raymond Doherty - 01 August 13:55

Business quote of the day.

New Statesman
US GDP rises 1.7 per cent in second-quarter
By New Statesman - 01 August 9:54

Federal consumption expenditures decline.

New Statesman
EADS to change name as Airbus Group
By New Statesman - 01 August 9:53

The aerospace and defense group will re-organise divisions phase wise from January 2014.

New Statesman
RBS likely to appoint Ross McEwan as new CEO
By New Statesman - 01 August 9:43

The appointment needs approval of Prudential Regulation Authority.

New Statesman
Morning Wrap: today's top business stories
By New Statesman - 01 August 9:31

News stories from around the web.

New Statesman
When will big Pharma finally go transparent?
By Heidi Vella - 31 July 10:42

Not quite there yet.

Pages